Hookipa Pharma Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the first quarter 2025 to a ratio of 30.14, above the company average. This is a clear sign of healthy business climate in the Major Pharmaceutical Preparations industry and improving liquidity at their respective customers, during the first quarter 2025. Average receivable collection period, for the Hookipa Pharma Inc in Mar 31 2025 quarter, has decreased to 12 days, compared to 23 days, in the Dec 31 2024 quarter.

If we take a look into Healthcare sector 42 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 415, from overall ranking in the fourth quarter 2024 at 2293.

What is Receivable Turnover Ratio?
What is Hookipa Pharma Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

HOOK Receivables Turnover Ratio	(Mar 31 2025) I. Quarter	(Dec 31 2024) IV. Quarter	(Sep 30 2024) III. Quarter	(Jun 30 2024) II. Quarter	(Mar 31 2024) I. Quarter
Y / Y Receivable Change	-94.66 %	-43.25 %	-52 %	-67.84 %	1938.32 %
Y / Y Revenue Change	-94.52 %	-81.72 %	-31.51 %	-51.85 %	1052.36 %
Receivable Turnover Ratio (TTM)	30.14	16.12	17.97	18.18	18.38
HOOK's Total Ranking	# 415	# 2293	# 537	# 2397	# 1691
Accounts Receivable average collection period days	12	23	20	20	20
Seq. Receivable Change	87.93 %	-10.49 %	295.12 %	-99.2 %	1898.43 %
Seq. Revenue Change	48.01 %	-71.21 %	264.57 %	-96.48 %	394.11 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 19
Healthcare Sector	# 43
Overall Market	# 415

Receivable Turnover Ratio Statistics
High	Average	Low
41.46	10.91	3.62
(Dec 31 2023)		(Dec 31 2021)

News about Hookipa Pharma inc Receivables Turnover Ratios

HOOKIPA Pharma to Showcase Promising Preclinical HB-700 Data at Upcoming RAS Industry Summit

HOOKIPA Pharma Inc. (NASDAQ: HOOK) is scheduled to unveil a comprehensive preclinical proof-of-concept package for its investigational drug HB-700 at the upcoming Industry Summit on RAS, slated for September 24-26, 2024. This presentation signifies a crucial milestone in the company s progress towards addressing RAS-driven cancers, illuminating HOOKIPA s commitment to advancing innovative therapeutic solutions. The RAS gene family has long been identified as a pivotal player in the onset and progression of various cancers, making it a prominent focus of research and development efforts in oncology. HOOKIPA Pharma, renowned for its specialized expertise in immunotherapy and virus-based therapies, continues to spearhead advancements in this critical field. With 12.5625 million shares outstanding and a current stock price of $4.50, HOOKIPA stands poised to make significant strides in the pharmaceutical landscape.

HOOK Company Profile • Back to HOOK Efficiency Comparisons • Compare HOOK Receivables Turnover Ratio to its Competitors

Financial Statements
Hookipa Pharma Inc 's Accounts Receivable	$ 1 Millions	Visit HOOK's Balance sheet
Hookipa Pharma Inc 's Sales TTM	$ 9 Millions	Visit HOOK's Income Statement
Sources of HOOK's Revenues		Visit HOOK's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
HOOK's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
HOOK's Growth Rates	HOOK's Roa	HOOK's Inventory Turnover Ratio	HOOK's Dividend Comparisons
HOOK's Profitability Ratios	HOOK's Roi	HOOK's Asset Turnover Ratio	HOOK's Dividend Growth
HOOK's Valuation Ratios	HOOK's Roe	HOOK's Financial Strength Ratios	HOOK's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2025, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Mar 31 2025	Receivable at quarter ending Mar 31 2025
Keros Therapeutics Inc	46.84	$ 239.195 Millions	$ 5.106 Millions
Longduoduo Co Ltd	45.04	$ 4.994 Millions	$ 0.111 Millions
Nature s Sunshine Products inc	41.79	$ 455.307 Millions	$ 10.894 Millions
Metagenomi Therapeutics Inc	40.18	$ 45.263 Millions	$ 1.127 Millions
Arvinas Inc	36.41	$ 426.900 Millions	$ 11.725 Millions
National Vision Holdings Inc	33.96	$ 1,791.121 Millions	$ 52.742 Millions
Lipocine Inc	33.55	$ 3.813 Millions	$ 0.114 Millions
Pavmed Inc	33.33	$ 2.183 Millions	$ 0.066 Millions
Lifemd Inc	30.98	$ 233.325 Millions	$ 7.532 Millions
Aim Immunotech Inc	30.74	$ 0.146 Millions	$ 0.005 Millions
Orchestra Biomed Holdings Inc	30.70	$ 2.886 Millions	$ 0.094 Millions
Invo Fertility Inc	30.57	$ 6.593 Millions	$ 0.216 Millions
Hookipa Pharma inc	30.14	$ 9.351 Millions	$ 0.310 Millions
U S Physical Therapy Inc	29.61	$ 699.458 Millions	$ 23.622 Millions
Aquestive Therapeutics Inc	29.54	$ 54.228 Millions	$ 1.836 Millions
Vivos Therapeutics Inc	29.23	$ 14.591 Millions	$ 0.499 Millions
Adaptimmune Therapeutics Plc	28.11	$ 179.639 Millions	$ 6.390 Millions
Agape Atp Corporation	27.90	$ 1.293 Millions	$ 0.046 Millions
Cv Sciences Inc	27.77	$ 13.973 Millions	$ 0.503 Millions
Nutriband Inc	27.76	$ 2.398 Millions	$ 0.086 Millions
Electrocore Inc	26.21	$ 25.660 Millions	$ 0.979 Millions
Fonar Corporation	25.93	$ 103.017 Millions	$ 3.974 Millions
Lineage Cell Therapeutics Inc	25.64	$ 9.557 Millions	$ 0.373 Millions
Safe Pro Group Inc	23.40	$ 2.354 Millions	$ 0.101 Millions
Sonida Senior Living Inc	22.97	$ 328.811 Millions	$ 14.313 Millions
Marpai Inc	22.81	$ 26.206 Millions	$ 1.149 Millions
Gossamer Bio Inc	22.51	$ 124.590 Millions	$ 5.535 Millions
Bespoke Extracts Inc	22.48	$ 1.120 Millions	$ 0.050 Millions
Clene Inc	21.87	$ 0.350 Millions	$ 0.016 Millions
Meiragtx Holdings Plc	21.74	$ 34.508 Millions	$ 1.587 Millions

Date modified: 2026-08-29T17:42:01+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.